{"id":"https://openalex.org/W2563325869","doi":"https://doi.org/10.1158/1538-7445.am2015-sy19-01","title":"Abstract SY19-01: Therapeutic network re-wiring of the DNA damage response can be used to enhance tumor killing by cytotoxic chemotherapy","display_name":"Abstract SY19-01: Therapeutic network re-wiring of the DNA damage response can be used to enhance tumor killing by cytotoxic chemotherapy","publication_year":2015,"publication_date":"2015-08-01","ids":{"openalex":"https://openalex.org/W2563325869","doi":"https://doi.org/10.1158/1538-7445.am2015-sy19-01","mag":"2563325869"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2015-sy19-01","doi":"https://doi.org/10.1158/1538-7445.am2015-sy19-01","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2015-sy19-01","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100747361","display_name":"Michael J. Lee","orcid":"https://orcid.org/0000-0003-3378-6196","observed_orcids":["https://orcid.org/0000-0003-3378-6196"]},"institutions":[{"id":"https://openalex.org/I4390039253","display_name":"Koch Institute for Integrative Cancer Research At MIT","ror":"https://ror.org/01xd6q208","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]},{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael J. Lee","raw_affiliation_strings":["MIT Koch Institute for Integrated Cancer Research, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MIT Koch Institute for Integrated Cancer Research, Cambridge, MA","institution_ids":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007083623","display_name":"Yogesh Dayma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039253","display_name":"Koch Institute for Integrative Cancer Research At MIT","ror":"https://ror.org/01xd6q208","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]},{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yogesh Dayma","raw_affiliation_strings":["MIT Koch Institute for Integrated Cancer Research, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MIT Koch Institute for Integrated Cancer Research, Cambridge, MA","institution_ids":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061333509","display_name":"Anne-Margriet Heijinks","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039253","display_name":"Koch Institute for Integrative Cancer Research At MIT","ror":"https://ror.org/01xd6q208","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]},{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anne-Margriet Heijinks","raw_affiliation_strings":["MIT Koch Institute for Integrated Cancer Research, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MIT Koch Institute for Integrated Cancer Research, Cambridge, MA","institution_ids":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111203143","display_name":"Stephen W. Morton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039253","display_name":"Koch Institute for Integrative Cancer Research At MIT","ror":"https://ror.org/01xd6q208","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]},{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen W. Morton","raw_affiliation_strings":["MIT Koch Institute for Integrated Cancer Research, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MIT Koch Institute for Integrated Cancer Research, Cambridge, MA","institution_ids":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038425734","display_name":"Erik C. Dreaden","orcid":"https://orcid.org/0000-0002-4954-8443","observed_orcids":["https://orcid.org/0000-0002-4954-8443"]},"institutions":[{"id":"https://openalex.org/I4390039253","display_name":"Koch Institute for Integrative Cancer Research At MIT","ror":"https://ror.org/01xd6q208","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]},{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erik C. Dreaden","raw_affiliation_strings":["MIT Koch Institute for Integrated Cancer Research, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MIT Koch Institute for Integrated Cancer Research, Cambridge, MA","institution_ids":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069094503","display_name":"Paula Therese Hammond","orcid":"https://orcid.org/0000-0002-9835-192X","observed_orcids":["https://orcid.org/0000-0002-9835-192X"]},"institutions":[{"id":"https://openalex.org/I4390039253","display_name":"Koch Institute for Integrative Cancer Research At MIT","ror":"https://ror.org/01xd6q208","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]},{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paula T. Hammond","raw_affiliation_strings":["MIT Koch Institute for Integrated Cancer Research, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MIT Koch Institute for Integrated Cancer Research, Cambridge, MA","institution_ids":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073615852","display_name":"Michael B. Yaffe","orcid":"https://orcid.org/0000-0002-9547-3251","observed_orcids":["https://orcid.org/0000-0002-9547-3251"]},"institutions":[{"id":"https://openalex.org/I4390039253","display_name":"Koch Institute for Integrative Cancer Research At MIT","ror":"https://ror.org/01xd6q208","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]},{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael B. Yaffe","raw_affiliation_strings":["MIT Koch Institute for Integrated Cancer Research, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MIT Koch Institute for Integrated Cancer Research, Cambridge, MA","institution_ids":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"75","issue":"15_Supplement","first_page":"SY19","last_page":"01"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.319599986076355,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.319599986076355,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.1436000019311905,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.09769999980926514,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.9860000014305115},{"id":"https://openalex.org/keywords/egfr-inhibition","display_name":"EGFR inhibition","score":0.8460000157356262},{"id":"https://openalex.org/keywords/fgfr-inhibition","display_name":"FGFR inhibition","score":0.9990000128746033},{"id":"https://openalex.org/keywords/topoisomerase-inhibitors","display_name":"topoisomerase inhibitors","score":0.8539999723434448},{"id":"https://openalex.org/keywords/platinum-based-drugs","display_name":"platinum drugs","score":0.7929999828338623},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.5450000166893005},{"id":"https://openalex.org/keywords/drug-timing","display_name":"drug timing","score":0.4659999907016754},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.43299999833106995},{"id":"https://openalex.org/keywords/caspase-8","display_name":"caspase-8","score":0.9710000157356262},{"id":"https://openalex.org/keywords/oncogene-addiction","display_name":"oncogene addiction","score":0.9539999961853027},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.746999979019165},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":1.0},{"id":"https://openalex.org/keywords/head-and-neck-cancer","display_name":"head and neck cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9430000185966492},{"id":"https://openalex.org/keywords/anticancer-drug-delivery","display_name":"anticancer drug delivery","score":0.6549999713897705}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5860468149185181},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5452303886413574},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5276901721954346},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.48120740056037903},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.47327113151550293},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.47259053587913513},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.4238366484642029},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.41932886838912964},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4120129942893982},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.28451216220855713},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.08802691102027893},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07683980464935303},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2015-sy19-01","doi":"https://doi.org/10.1158/1538-7445.am2015-sy19-01","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2015-sy19-01","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8560000061988831}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2190216829","https://openalex.org/W2004851576","https://openalex.org/W7099623968","https://openalex.org/W2088954900","https://openalex.org/W7074673817","https://openalex.org/W2585035040","https://openalex.org/W2460723879","https://openalex.org/W2123776480","https://openalex.org/W2101322783","https://openalex.org/W2072978123"],"abstract_inverted_index":{"Abstract":[0],"Dynamic":[1],"re-wiring":[2,28,230,245,290,320],"of":[3,14,38,51,69,129,201,213,231,242,265,275,287,321,339,344],"signaling":[4,132,145,233],"networks":[5],"is":[6,95,186],"a":[7,125],"prominent":[8],"mechanism":[9,111],"responsible":[10,112],"for":[11,113,143,291,348],"the":[12,36,98,106,208,224,228,262,285,295,322,340,345],"development":[13],"resistance":[15],"to":[16,34,40,81,198,329],"many":[17],"molecular-targeted":[18],"anti-cancer":[19,42,292],"agents.":[20,43,108],"Here":[21],"we":[22,64,239],"show":[23,65,268],"how":[24],"this":[25,114,243],"same":[26],"dynamic":[27,229,244],"process":[29,246],"can":[30,219,326],"be":[31,327],"used":[32,328],"therapeutically":[33],"enhance":[35,330],"response":[37,80,197,226,325],"tumors":[39],"cytotoxic":[41,107,334],"Using":[44],"cell":[45,56,77,120,161,164,232],"lines":[46],"and":[47,59,61,84,140,156,170,278],"murine":[48,276],"tumor":[49,119,160,225,280,331],"models":[50],"triple-negative":[52],"breast":[53],"cancer,":[54,58,63],"non-small":[55],"lung":[57],"head":[60],"neck":[62],"that":[66,175,185,207,253,269],"chronic":[67],"inhibition":[68],"EGFR":[70,255],"and/or":[71],"FGFR":[72],"driver":[73],"oncogenes":[74],"dramatically":[75],"enhances":[76],"death":[78],"in":[79,133,154,193,216,235,282,294],"topoisomerase":[82],"inhibitors":[83,102,256],"platinum":[85],"DNA":[86,130,202,323],"crosslinking":[87],"drugs.":[88],"In":[89],"marked":[90],"contrast,":[91],"no":[92],"such":[93],"sensitization":[94,121],"observed":[96],"when":[97],"growth":[99,116],"factor":[100,117],"receptor":[101],"are":[103],"co-administered":[104],"with":[105,159],"The":[109],"molecular":[110],"time-dependent":[115],"inhibitor-induced":[118],"was":[122],"explored":[123],"using":[124],"systems":[126],"biology-based":[127],"model":[128],"damage":[131,324],"which":[134],"protein":[135],"kinase":[136],"activities,":[137],"substrate":[138],"phosphorylation,":[139],"phosphoprotein-binding":[141],"events":[142],"multiple":[144],"pathways":[146,234],"were":[147],"quantitatively":[148],"measured":[149],"at":[150,257],"densely":[151],"sampled":[152],"points":[153],"time,":[155],"mathematically":[157],"correlated":[158],"responses":[162],"including":[163],"cycle":[165],"arrest,":[166],"cytokine":[167],"production,":[168],"autophagy,":[169],"apoptosis.":[171],"This":[172,204],"analysis":[173],"revealed":[174],"sustained":[176],"EGFR/FGFR":[177],"suppression":[178],"unmasks":[179],"an":[180,194],"apoptotic":[181,196],"network":[182,289,319],"involving":[183],"Caspase-8":[184],"normally":[187],"suppressed":[188],"by":[189,247,261,333],"oncogene":[190],"addiction,":[191],"resulting":[192],"enhanced":[195],"equivalent":[199],"amounts":[200],"damage.":[203],"discovery":[205],"demonstrates":[206],"timing":[209],"interval":[210],"between":[211],"administration":[212],"different":[214],"drugs":[215],"combination":[217],"chemotherapy":[218],"have":[220],"profound":[221],"effects":[222],"on":[223],"through":[227],"real":[236],"time.":[237],"Finally,":[238],"take":[240],"advantage":[241],"developing":[248],"tumor-targeted":[249],"time-staggered":[250],"release":[251,264],"nanoparticles":[252,271],"deliver":[254],"early":[258],"times":[259],"followed":[260],"delayed":[263],"doxorubicin.":[266],"We":[267],"these":[270],"cause":[272],"dramatic":[273],"regression":[274],"NSCLC":[277],"TNBC":[279],"xenografts":[281],"vivo,":[283],"substantiating":[284],"utility":[286],"therapeutic":[288],"therapy":[293],"clinic.":[296],"Citation":[297],"Format:":[298],"Michael":[299,315],"J.":[300],"Lee,":[301],"Yogesh":[302],"Dayma,":[303],"Anne-Margriet":[304],"Heijinks,":[305],"Stephen":[306],"W.":[307],"Morton,":[308],"Erik":[309],"C.":[310],"Dreaden,":[311],"Paula":[312],"T.":[313],"Hammond,":[314],"B.":[316],"Yaffe.":[317],"Therapeutic":[318],"killing":[332],"chemotherapy.":[335],"[abstract].":[336],"In:":[337],"Proceedings":[338],"106th":[341],"Annual":[342],"Meeting":[343],"American":[346],"Association":[347],"Cancer":[349,359],"Research;":[350],"2015":[351],"Apr":[352],"18-22;":[353],"Philadelphia,":[354],"PA.":[355],"Philadelphia":[356],"(PA):":[357],"AACR;":[358],"Res":[360],"2015;75(15":[361],"Suppl):Abstract":[362],"nr":[363],"SY19-01.":[364],"doi:10.1158/1538-7445.AM2015-SY19-01":[365]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2017-01-06T00:00:00"}